WallStSmart

Nomura Holdings Inc ADR (NMR)vsStreamex Corp (STEX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 1596652032% more annual revenue ($2.33T vs $146,000). NMR leads profitability with a 17.3% profit margin vs 0.0%. NMR earns a higher WallStSmart Score of 84/100 (A-).

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

STEX

Avoid

26

out of 100

Grade: F

Growth: 4.3Profit: 2.5Value: 5.0Quality: 6.5
Piotroski: 3/9Altman Z: -11.84

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.2x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

STEX2 strengths · Avg: 10.0/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Areas to Watch

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

STEX4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$130.36M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bull Case : STEX

The strongest argument for STEX centers on Price/Book, Debt/Equity.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Bear Case : STEX

The primary concerns for STEX are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

NMR profiles as a growth stock while STEX is a value play — different risk/reward profiles.

STEX carries more volatility with a beta of 2.01 — expect wider price swings.

NMR is growing revenue faster at 31.2% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 26/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Streamex Corp

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Streamex Corp. The company is headquartered in Winter Park, Florida.

Want to dig deeper into these stocks?